Health FDA Reform, Pharmaceuticals
November 21st, 2011 Podcast

Paul Howard and former FDA Commissioner, Dr. Andrew C. von Eschenbach, discuss the FDA's recent decision revoking Avastin's approval for the treatment of metastatic breast cancer

Paul Howard and former FDA Commissioner, Dr. Andrew C. von Eschenbach, discuss the FDA's recent decision revoking Avastin's approval for the treatment of metastatic breast cancer.